This study analysed the impact of liver steatosis (LS) on the parameters of iron overload in 110 patients with non-transfusion dependent thalassaemia (NTDT). LS was diagnosed by ultrasound. Liver iron concentration (LIC) measurements were available for 64 patients who underwent a magnetic resonance imaging (MRI) scan. LS was frequent (35Á5%) and was significantly more prevalent in males than in females (49Á0% vs. 24Á6%, P = 0Á008). Patients with LS had significant higher levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), ALT/AST ratio and ferritin than those without, but LIC values were comparable. An ALT/AST ratio >0Á89 predicted the presence of LS with a sensitivity of 0Á872 and a specificity of 0Á901 (P < 0Á0001). Ferritin levels correlated with LIC values (R = 0Á558, P < 0Á0001) but the correlation was stronger in patients without LS (R = 0Á656, P < 0Á0001) than in patients with LS (R = 0Á426, P = 0Á05). LS is a frequent issue in NTDT patients and should be suspected in the presence of an ALT/AST ratio >0Á89. Recently, serum ferritin thresholds that predict clinically relevant LIC for guiding iron chelation therapy when MRI is unavailable have been determined. Our data show that LS may cause increase in ferritin levels and may be responsible for anticipating/exceeding chelation treatment in NTDT patients in the absence of LIC evaluation.
Summary
This study analysed the impact of liver steatosis (LS) on the parameters of iron overload in 110 patients with non-transfusion dependent thalassaemia (NTDT). LS was diagnosed by ultrasound. Liver iron concentration (LIC) measurements were available for 64 patients who underwent a magnetic resonance imaging (MRI) scan. LS was frequent (35Á5%) and was significantly more prevalent in males than in females (49Á0% vs. 24Á6%, P = 0Á008). Patients with LS had significant higher levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), ALT/AST ratio and ferritin than those without, but LIC values were comparable. An ALT/AST ratio >0Á89 predicted the presence of LS with a sensitivity of 0Á872 and a specificity of 0Á901 (P < 0Á0001). Ferritin levels correlated with LIC values (R = 0Á558, P < 0Á0001) but the correlation was stronger in patients without LS (R = 0Á656, P < 0Á0001) than in patients with LS (R = 0Á426, P = 0Á05). LS is a frequent issue in NTDT patients and should be suspected in the presence of an ALT/AST ratio >0Á89. Recently, serum ferritin thresholds that predict clinically relevant LIC for guiding iron chelation therapy when MRI is unavailable have been determined. Our data show that LS may cause increase in ferritin levels and may be responsible for anticipating/exceeding chelation treatment in NTDT patients in the absence of LIC evaluation.
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Fatty liver (liver steatosis) is a common abnormality encountered in Western countries among patients undergoing imaging of the abdomen. Fatty liver is frequently associated with alcoholic liver disease, caused by excess alcohol consumption, or with non-alcoholic fatty liver disease (NAFLD), related to insulin resistance and metabolic syndrome. Non-alcoholic fatty liver disease is now recognized as a main cause of chronic liver diseases, including liver cirrhosis and hepatocellular carcinoma (HCC) in Western countries (McCullough, 2002; Sass et al, 2005; Farrell & Larter, 2006) . Similarly, the incidence of the liver impairment and HCC is increasing in patients with non-transfusion-dependent thalassaemia (NTDT), due to longer survival and consequential longer exposure to the noxious effects of hepatotropic viruses and iron (Borgna-Pignatti et al, 2014) . However, in numerous conditions associated with fatty liver, steatosis may progress to steatohepatitis (with inflammation, cell injury or fibrosis accompanying steatosis) and then to cirrhosis, where the increased ferritin levels frequently observed are markers of systemic inflammation, unrelated to the presence of iron overload (Shim et al, 2012) . On the other hand, several studies have documented a strict relationship between serum ferritin levels and liver iron concentration (LIC) in patients with iron loading anaemia, including the main NTDT subtypes. Furthermore, while serum alanine aminotransferase (ALT) levels in thalassaemia patients generally increased as a consequence of iron overload and decreased following its clearance (Ricchi et al, 2010) , a high ALT to serum aspartate aminotransferase (AST) ratio was seen to be an independent risk factor of the presence of NAFLD in the general population (Lee et al, 2010) .
To our knowledge, reliable data about liver steatosis (LS) occurrence, its pathophysiological basis and consequences among NTDT patients are lacking.
The purpose of this study was to retrospectively analyse the occurrence of liver steatosis and its impact on iron overload and liver parameters in all our population of NTDT patients.
Methods

Study population
One hundred and ten NTDT patients followed at the Azienda Ospedaliera di Rilievo Nazionale Cardarelli centre in Naples, Italy, were retrospectively evaluated. Patients with haemoglobin S/b-thalassaemia were excluded from the analysis.
LIC measurements were available for 64 patients (54%) who underwent a magnetic resonance imaging (MRI) scan within the Myocardial Iron Overload in Thalassaemia (MIOT) network. The MIOT Network is an Italian Network of 70 thalassaemia centres and nine magnetic Resonance Imaging (MRI) centres where MRI examinations are performed using homogeneous, standardized and validated procedures (Meloni et al, 2009) .
The study complied with the Declaration of Helsinki. All patients gave written informed consent to the protocol. The study was approved by the Ethics Committee of the Cardarelli Hospital, Napoli.
Assessment of hepatic steatosis
Liver steatosis was diagnosed by ultrasound US.
A qualitative visual assessment of hepatic echogenicity was performed. Hepatic steatosis on US appears as a diffuse increase in hepatic echogenicity, or "bright liver", due to increased reflection of US from the liver parenchyma, which is caused by intracellular accumulation of fat vacuoles (Schwenzer et al, 2009) .
A meta-analysis showed that the overall sensitivity and specificity of ultrasonography for the detection of moderate to severe fatty liver compared to histology were 84Á8% and 93Á6%, respectively (Hernaez et al, 2011) .
Laboratory investigations
Blood was collected by venepuncture, allowed to clot, then centrifuged to obtain serum samples. Laboratory investigations included: (i) iron status as indicated by serum ferritin levels; (ii) liver function as indicated by serum levels of ALT and AST. Ferritin and liver transaminases were determined in each patient at least three times a year and the mean was calculated to generate one value per patient. All parameters were determined by commercially available kits.
The ALT/AST ratio was calculated.
Iron overload assessment
The T2* technique was used for hepatic iron overload assessment. Its reproducibility and its transferability within the MIOT network had been previously demonstrated . A single mid-transverse slice was obtained at nine echo times (TEs) in a single end-expiratory breath-hold. The multi-echo sequence parameters were as follows: flip angle 25°; matrix 192 9 256 pixels; field of view 40 9 40 cm; bandwidth 62Á5 kHz; slice thickness 8Á0 mm; repetition time 25 ms.
Image analysis was performed using a custom-written, previously validated software program (HIPPO MIOT â ) (Positano et al, 2007) . The T2* value was calculated in a large region of interest (ROI) of standard dimension, chosen in a homogeneous area of parenchyma without blood vessels. Care was taken to avoid selecting the ROI in the posterior lateral (VII) and medial (VIII) segments, which are more prone to susceptibility artifacts (Meloni et al, 2011) . As suggested (Meloni et al, 2013) , liver T2* values were converted into LIC values using the calibration curve introduced by Wood et al (2005) .
Statistical analysis
All data were analysed using SPSS version 13.0 (SPSS Inc., Chicago.IL, USA). Continuous variables were described as mean AE standard deviation (SD). Categorical variables were expressed as frequencies and percentages. The normality of distribution of the parameters was assessed by using the Kolmogorov-Smirnov test.
For continuous values with normal distribution, the comparison between two groups was made by independent-samples t-test. Wilcoxon's signed rank test was applied for continuous values with non-normal distribution.
Correlation analysis was performed using Pearson's or Spearman's test where appropriate.
To determine the best ALT/AST ratio cut-off for discriminating between LS versus no LS, the maximum sum of sensitivity and specificity was calculated from receiver-operating characteristic (ROC) curve analysis.
A 2-tailed probability <0Á05 was considered statistically significant.
Results
The characteristics of our NTDT patients are shown in Table I . Patient age ranged from 10 to 81 years and 44Á5% were males. Fifty (45Á5%) patients have never been transfused. Among the remaining 60 patients, 24 (40%) had received occasional red blood cell transfusions (<6/year), 12 (20%) had received a maximum of two transfusions/year, 12 (20%) had only been transfused during pregnancy, 7 (11Á7%) had been transfused during pregnancy and received occasional transfusions during their life, and 5 (8Á3%) had received only one transfusion/year.
Fifty-five (50Á0%) patients had a history of iron chelation therapy, due to the presence of either a LIC >5 mg Fe/g dry weight or serum ferritin levels >800 lg/l. Specifically, 6 (10Á9%) patients had previously been chelated, but not at the time of the steatosis assessment, 30 (54Á5%) had recent continuous treatment (13 desferrioxamine, 11 deferasirox, 6 deferiprone), and 19 (34Á5%) had previously required continuous chelation and still needed infrequent iron chelation treatment for persistent and/or recurrent abnormal parameters of iron loading.
Liver steatosis was frequently (35Á5%) encountered among our NTDT patients and was significantly more prevalent in males compared to females (49Á0% vs. 24Á6%, P = 0Á008). Moreover, males showed significantly higher ALT and AST levels than females (ALT: 25Á10 AE 16Á76 vs. 17Á36 AE 10Á77 u/l, P = 0Á002; AST: 27Á31 AE 10Á28 vs. 20Á74 AE 8Á05 u/l, P < 0Á0001). The ALT/AST ratio and LIC values were comparable between the sexes. A significant positive correlation was detected between age and AST levels (R = 0Á210; P = 0Á028) and age and serum ferritin levels (R = 0Á308; P = 0Á001). Table II shows the comparison between patients with and without liver steatosis. Patients with steatosis were older, but this did not reach statistical significance. The body mass index (BMI) was significantly higher in the steatosis group. Patients with liver steatosis had significantly higher levels of ALT, AST, and ferritin and higher ALT/AST ratio than those without, but LIC values were comparable.
At ROC curve analysis, an ALT/AST ratio >0Á89 predicted the presence of liver steatosis with a sensitivity of 0Á87 and a specificity of 0Á90 (P < 0Á0001). The area under the curve was 0Á89 (95% confidence interval : 0Á82-0Á94) ( Figure S1 ).
Overall, ferritin levels positively correlated with LIC values (R = 0Á558, P < 0Á0001); however, there was a strong relationship between ferritin and LIC values in patients without steatosis (R = 0Á656, P < 0Á0001) whereas the correlation was moderate patients with steatosis (R = 0Á426, P = 0Á05) (Figure 1) .
There was no correlation between LIC and ALT/AST ratio (R = 0Á152, P = 0Á231).
Discussion
Liver steatosis in NFALD is increasingly frequently diagnosed in the general population in Western countries. Our data showed for the first time that liver steatosis was a prevalent (35%) disease in NTDT patients, particularly males. However, it should be noted that US was used instead of histology as the standard for diagnosing the liver steatosis; US has a reported diagnostic accuracy of 67-94% (Joseph et al, 1991; Graif et al, 2000; Hamaguchi et al, 2007) . In addition, liver steatosis in NALFD is considered to be a hepatic manifestation of metabolic syndrome, the evaluation of which was limited to BMI assessment in this study. Further studies are needed to confirm our results, also considering other History of transfusion, n (%) 60 (54Á5) History of chelation, n (%) 55 (50%) Splenectomy, n (%) 38 (34Á5) Hepatitis C virus positivity, n (%) 5 (4Á5) Body mass index (kg/m 2 ) 2 3 Á69 AE 3Á56 Liver steatosis, n (%) 39 (35Á5) Serum ferritin levels (lg/l)
ALT, alanine aminotransferase; AST, aspartate aminotransferase; LIC, liver iron concentration; MRI, magnetic resonance imaging. 
ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; HCV, hepatitis C virus; LIC, liver iron concentration.
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ª 2018 John Wiley & Sons Ltd diagnostic parameters for metabolic syndrome and NFALD, such as Insulin resistance (IR), and using alternative imaging techniques, such as MRI and computed tomography. Patients with NTDT are, above all, at risk of iron overload, liver damage, liver fibrosis and HCC. Therefore, these findings should be taken in account in the management of patients with NTDT because, in addition to iron overload, liver steatosis may be responsible for a further increase in liver damage. In fact, hepatic steatosis and NFALD can have different influences on a liver affected by other diseases and might synergistically act to worsen fibrosis (Persico & Iolascon, 2010) . Accordingly, our patients with liver steatosis, despite having comparable iron burden, had higher levels of serum transaminases than those without, even within the normal range in both sexes. Interestingly, as found in the general population, the ability of a high ALT/AST ratio to predict the presence of liver steatosis was maintained in our NTDT patients.
A number of previous studies have examined the frequent presence of hyperferritinaemia, with or without increased hepatic iron storage, in patients with NAFLD (Fargion et al, 2001; Bugianesi et al, 2004; Hsiao et al, 2004; Zelber-Sagi et al, 2007; Brudevold et al, 2008; Nakagawa et al, 2008; Licata et al, 2009; Cales et al, 2010; Valenti et al, 2010; Yoneda et al, 2010; Fracanzani et al, 2011; Manousou et al, 2011; Sumida et al, 2011) , but the role in liver disease progression and the extension of iron burden still need to be clarified in this pathology. In this study, using validated technology to estimate iron overload, we had also the opportunity to ascertain whether the presence or the absence of liver steatosis had an impact on the correlation between LIC and ferritin levels in patients with NTDT, where iron overload is commonly encountered. In fact, there is an expanding literature across a variety of iron loading diseases, including different NTDT subtypes, showing a significant positive correlation between serum ferritin and LIC (Pakbaz et al, 2007; Taher et al, 2008; Lai et al, 2011; Cheong et al, 2014; Porter et al, 2017) . A serum ferritin level of 800 lg/l, where complications are commonly found, had the highest overall accuracy for predicting LIC ≥5 mg Fe/g dw (threshold for the initiation of chelation therapy) (Taher et al, 2013 (Taher et al, , 2014 . For this reason, LIC assessment by MRI should be the recommended resource of quantifying iron overload in patients with NTDT to guide iron chelation decisions. But, when MRI technology is unavailable, based on the described reciprocal relationship, it would be useful if the management of iron chelation therapy could also be determined using only serum ferritin measurements, (Saliba et al, 2017) . However, due to the presence of potential confounders, further investigation of this relationship is needed before serum ferritin can be widely used for decisions regarding chelation therapy in NTDT patients. In fact, apart from rare paradoxical cases where ferritin levels are high and iron overload is absent (Fig 1) , our data comprehensively showed that the presence of liver steatosis had a severe impact on the correlation between ferritin and LIC values, as it was responsible for an increase in serum ferritin level in presence of comparable level of iron overload.
In conclusion, our data indicated that, liver steatosis is a confounder of the relationship between ferritin and LIC as it may cause overestimation of the extent of iron burden and be responsible for anticipating or exceeding chelation treatment in NTDT patients in the absence of a LIC assessment. the paper. AS, SC, AP, PC and AF collected the data and contributed to the interpretation of the results. All authors contributed to critical revision and final approval of the version to be published.
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